News|Articles|April 9, 2025
Evolving Complexities In BioAnalysis: Addressing Sensitivity, Selectivity and Sample Complexity
Author(s)Sannova Analytical
Evolving therapeutic modalities increase bioanalytical complexity, making ion mobility spectrometry–mass spectrometry (IMS-MS) crucial for enhanced sensitivity and selectivity.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
2
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
3
How Mitigation and Maintenance Protect Against Future Risk
4
Behind the Headlines Episode 29: 2025 Year in Review
5
